StoneX Group’s ENvue Medical Inc FEED Stock Holding History

StoneX Group’s Portfolio FEED Stock Details FEED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6	Closed	-$3.12K	–	610
2022 Q4	$3.12K	Buy	+6	New	+$4.94K	﹤0.01%	514

Other funds holding FEED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AFS

Amtrust Financial Services New York $336M AUM 16.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NewSquare Capital Newtown Square, Pennsylvania $1.35B AUM 34.37% 1-Year Est. Return

StoneX Group's FEED Position: Q1 2023 in Review

StoneX Group sold out of ENvue Medical Inc (FEED) in Q1 2023, closing a stake of 6 shares — an estimated $3.12K sold.

StoneX Group first reported a position in FEED in Q4 2022 and held it in 1 quarter. The position peaked at $3.12K in Q4 2022. 7 funds tracked by Wall St. Rank hold FEED as of Q1 2023.

StoneX Group reported no remaining ENvue Medical Inc position as of Q1 2023 after selling out during the quarter.
StoneX Group sold 6 ENvue Medical Inc shares in Q1 2023, an estimated $3.12K.
StoneX Group first reported a position in ENvue Medical Inc in Q4 2022 and held it in 1 quarter.
StoneX Group's ENvue Medical Inc position peaked at $3.12K in Q4 2022.
7 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q1 2023.

Based on StoneX Group's 13F filing for Q1 2023, filed 11 May 2023.